DK0539575T3 - Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner. - Google Patents

Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.

Info

Publication number
DK0539575T3
DK0539575T3 DK92913637.2T DK92913637T DK0539575T3 DK 0539575 T3 DK0539575 T3 DK 0539575T3 DK 92913637 T DK92913637 T DK 92913637T DK 0539575 T3 DK0539575 T3 DK 0539575T3
Authority
DK
Denmark
Prior art keywords
ones
metastasis
pyridyloxasol
inhibition
cancer patients
Prior art date
Application number
DK92913637.2T
Other languages
Danish (da)
English (en)
Inventor
Alan J Bitonti
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0539575T3 publication Critical patent/DK0539575T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK92913637.2T 1991-05-14 1992-04-14 Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner. DK0539575T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69982191A 1991-05-14 1991-05-14

Publications (1)

Publication Number Publication Date
DK0539575T3 true DK0539575T3 (da) 1997-10-27

Family

ID=24811050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913637.2T DK0539575T3 (da) 1991-05-14 1992-04-14 Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.

Country Status (12)

Country Link
US (1) US5610171A (de)
EP (1) EP0539575B1 (de)
AT (1) ATE155686T1 (de)
AU (1) AU645217B2 (de)
CA (1) CA2087334A1 (de)
DE (1) DE69221069T2 (de)
DK (1) DK0539575T3 (de)
ES (1) ES2106874T3 (de)
GR (1) GR3024832T3 (de)
IE (1) IE921524A1 (de)
NZ (1) NZ242677A (de)
WO (1) WO1992020337A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070009529A1 (en) * 2002-03-26 2007-01-11 New York University Agents that dissolve arterial thrombi
US8753631B2 (en) * 2009-05-01 2014-06-17 New York University Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935902A1 (de) * 1979-09-05 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln Oxazolinalkansaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
ZA908852B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones

Also Published As

Publication number Publication date
DE69221069T2 (de) 1997-11-13
GR3024832T3 (en) 1998-01-30
DE69221069D1 (de) 1997-08-28
CA2087334A1 (en) 1992-11-15
IE921524A1 (en) 1992-11-18
US5610171A (en) 1997-03-11
EP0539575B1 (de) 1997-07-23
NZ242677A (en) 1997-06-24
EP0539575A1 (de) 1993-05-05
ES2106874T3 (es) 1997-11-16
ATE155686T1 (de) 1997-08-15
AU2167692A (en) 1992-12-30
AU645217B2 (en) 1994-01-06
WO1992020337A2 (en) 1992-11-26
WO1992020337A3 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
ATE164593T1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
MY125587A (en) Protien kinase c inhibitors.
ATE155143T1 (de) 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
ATE364592T1 (de) Tyrosinderivate
DK0705100T3 (da) Terapeutiske substituerede guanidiner
FI941519A (fi) Farnesyyliproteiinitransferaasin heterosyklisiä inhibiittoreita
NO20010053L (no) Farnesyl proteintransferaseinhibitorer for behandling av artropatier
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
DE60033316D1 (de) Tricyclische proteinkinasehemmer
DK0610317T3 (da) Inhibitorer af dipeptidyl-aminopeptidase type IV
TR199900048T2 (xx) Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
FI962246A (fi) Apoptoosia inhiboivat koostumukset, koostumusten puhdistusmenetelmät ja niiden käyttö
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
DE69413815D1 (de) Inhibierung des Haarwuchses
DE69427756D1 (de) Hemmung des haarwachstum
DE69220382D1 (de) Verwendung von Peptidderivaten
FI923280A0 (fi) Aminosubstituerade piperazinderivat.
ATE242234T1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
KR950700412A (ko) 종양성장을 저해시키는 단백질 성분물(protein compound capable of inhibiting tumoral growth)
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
DE69231390D1 (de) Anisotropische Ablagerung von Dielektrika
DK0530937T3 (da) Inhibitor med collagenfremkaldt blodpladeaggregering
DK0539575T3 (da) Hæmning af metastasering hos kræftpatienter med pyridyloxasol-2-oner.
FI925144A (fi) Anvaendning av inhibitorer foer faergutvecklingen i kromogena bestaemningar
ITTO930549A0 (it) Trattamento superficiale di refrattari